ReviewCancers2025

Molecular Biomarkers in Borderline Ovarian Tumors: Towards Personalized Treatment and Prognostic Assessment.

Stefania Drymiotou et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.